HealZen Therapeutics

HealZen Therapeutics Co., Ltd. is an innovative small-molecule drug research and development enterprise with international vision. The company adheres to the principle of "developing righteous and effective medicines with a heart of benevolence," focusing on the research and development of innovative drugs in the fields of tumor immunology and liver diseases. Currently, one of the company’s anti-tumor drugs has entered Phase I clinical trials, with multiple projects in the candidate development stage. Additionally, one drug for liver disease treatment has been successfully out-licensed.